Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
Get Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.34), $0.33 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.24 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Synovus Financial (SNV) Misses Q1 EPS by 20c
- Equifax (EFX) shares tumble as Q2, full-year guidance falls short
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!